Category Archives: Fixing Big Pharma Research

If you want efficient and effective R&D, get your mix of solution shops and production shops right

Posted on November 1, 2013 by Alexander Szewczak

I had the good fortune to attend a series of seminars by Clayton Cristensen last Spring.  One conceptual framework that Clay described is the three basic types of businesses, and I think it has a lot of relevance for Pharma … Continue reading →

Posted in Fixing Big Pharma Research, Management | Tagged , , , , , , | Leave a comment

Fixing Big Pharma Research: Two Things about Restructuring

Posted on October 8, 2013 by Alexander Szewczak

For a pharmaceutical company restructuring to be successful, senior management has to get two things right: 1)  Restructuring is a forward-looking process.  Management has to plan the new organization so that it is successful in the future. People, processes, organizations, … Continue reading →

Posted in Fixing Big Pharma Research, Management | Tagged , , , , , , | Leave a comment

Fixing Big Pharma Research: Expected cost savings have to be recoverable

Posted on September 7, 2013 by Alexander Szewczak

All too often the cost savings from efficiency improvements of various kinds are dramatically over estimated, especially when large numbers of small improvements are aggregated. Companies of all kinds (not just Pharma) often justify investments in new equipment or software … Continue reading →

Posted in Fixing Big Pharma Research, Management | Tagged , , , , , | Leave a comment